Does CAPLACIZUMAB Cause Oligohydramnios? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Oligohydramnios have been filed in association with CAPLACIZUMAB (Cablivi). This represents 4.8% of all adverse event reports for CAPLACIZUMAB.
7
Reports of Oligohydramnios with CAPLACIZUMAB
4.8%
of all CAPLACIZUMAB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Oligohydramnios From CAPLACIZUMAB?
Of the 7 reports, and 3 (42.9%) were considered life-threatening.
Is Oligohydramnios Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPLACIZUMAB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does CAPLACIZUMAB Cause?
Off label use (26)
Condition aggravated (13)
Platelet count decreased (12)
Drug ineffective (10)
Maternal exposure during pregnancy (10)
Pyrexia (10)
Thrombotic thrombocytopenic purpura (10)
Foetal exposure during pregnancy (9)
Foetal growth restriction (9)
Haemorrhage (9)
What Other Drugs Cause Oligohydramnios?
IBUPROFEN (233)
VALSARTAN (228)
ACETAMINOPHEN (189)
INDOMETHACIN (166)
DICLOFENAC (109)
TRASTUZUMAB (106)
LOSARTAN (101)
DOXORUBICIN (68)
FUROSEMIDE (65)
CYCLOPHOSPHAMIDE (62)
Which CAPLACIZUMAB Alternatives Have Lower Oligohydramnios Risk?
CAPLACIZUMAB vs CAPLACIZUMAB-YHDP
CAPLACIZUMAB vs CAPMATINIB
CAPLACIZUMAB vs CAPREOMYCIN
CAPLACIZUMAB vs CAPSAICIN
CAPLACIZUMAB vs CAPTOPRIL